G6PD deficiency—does it alter the course of COVID-19 infections? Tsz Yuen AuOskar Wojciech WiśniewskiLidia Gil Review Article Open access 11 March 2023 Pages: 1629 - 1636
Relationship of paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size to disease burden and risk of major vascular events in untreated patients: results from the International PNH Registry David DingliJaroslaw P. MaciejewskiAlexander D. Kulagin Review Article Open access 18 May 2023 Pages: 1637 - 1644
Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective Satoshi Yamasaki Review Article 12 May 2023 Pages: 1645 - 1656
Sickle cell disease and acute leukemia: one case report and an extensive review Giovanna CannasSolène PoutrelArnaud Hot Original Article 03 June 2023 Pages: 1657 - 1667
Timing matters: An analysis of the relationship between red cell transfusion timing and hospitalization outcomes in sickle cell crisis patients using the National Inpatient Sample database Zubair Hassan BodlaMariam HashmiSue-Wei Luu Original Article 30 May 2023 Pages: 1669 - 1676
Trends in outcomes and racial disparities in adult hospitalizations for immune thrombocytopenia over a decade Rafaella LitvinMona DasguptaHafeez Shaka Original Article 06 May 2023 Pages: 1677 - 1686
Autoimmune Hemolytic Anemia in the Pediatric Age Group: The Egyptian Experience Amina Abdel-SalamSherifa Tarek BassiouniEman Shafik Shafie Original Article Open access 24 April 2023 Pages: 1687 - 1694
All-trans retinoic acid added to treatment of primary immune thrombocytopenia: a systematic review and meta-analysis Jinjun YangLei ZhaoYu Wu Original Article 11 May 2023 Pages: 1695 - 1704
Hemophagocytic lymphohistiocytosis in inflammatory bowel disease: a nationwide analysis Amir A. MahmoudAli AbdelhayTalha Malik Original Article 24 April 2023 Pages: 1705 - 1711
Differentiation syndrome and coagulation disorder — comparison between treatment with oral and intravenous arsenics in pediatric acute promyelocytic leukemia Jie-Si LuoXiao-Li ZhangLi-Bin Huang Original Article Open access 18 May 2023 Pages: 1713 - 1721
Estimating prognostic relevant cutoff values for a multiplex PCR detecting BCR::ABL1 in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy in resource-limited settings Saifu HailuSamuel KindeAmha Gebremedhin Original Article Open access 22 May 2023 Pages: 1723 - 1729
CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease Yao-jia ShenYi ZhangHong-hu Zhu Original Article 05 May 2023 Pages: 1731 - 1738
Reduced plasma coagulation factor XIII in patients with acute leukemia in remission during consolidation chemotherapy cycles Xia-Ye LvZi-Jian Li Original Article 09 May 2023 Pages: 1739 - 1744
Contributions of bone marrow monocytes/macrophages in myeloproliferative neoplasms with JAK2V617F mutation Wenjuan FanWeijie CaoWang Ma Original Article 26 May 2023 Pages: 1745 - 1759
Real-world Imatinib Mesylate Treatment in Patients with Chronic Myeloid Leukemia: The Importance of Molecular Monitoring and the Early Molecular Response Amanda Pifano Soares FerreiraFernanda Salles SeguroIsrael Bendit Original Article Open access 13 April 2023 Pages: 1761 - 1771
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma Grzegorz S. NowakowskiDok Hyun YoonGilles Salles Original Article Open access 12 May 2023 Pages: 1773 - 1787
Efficacy and safety-related factors of BTK inhibitors as a bridge to CAR-T therapy in R/R FL Xiupeng YeXuemei FanQi Deng Original Article 12 May 2023 Pages: 1789 - 1799
m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2 Xiaoqing HuangZhiyong YangXingxing Long Original Article 24 May 2023 Pages: 1801 - 1810
Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort study Juliette PénichouxHélène LanicFabrice Jardin Original Article Open access 14 April 2023 Pages: 1811 - 1823
A novel prognostic nomogram for adult acute lymphoblastic leukemia: a comprehensive analysis of 321 patients Qian ZhangMei-Juan HuangYuan-Zhong Chen Original Article 13 May 2023 Pages: 1825 - 1835
Infectious complications following CAR-t cell therapy for B cell non-Hodgkin lymphoma: a single-center experience and review of the literature Santiago MercadalCarlos A. GomezDaniel R Couriel Original Article 29 May 2023 Pages: 1837 - 1843
RNA-seq analysis reveals candidate genes associated with proliferation, invasion, and migration in BCL11A knockdown B-NHL cell lines Jiawei YinXiaoli XieLijuan Wang Original Article 06 May 2023 Pages: 1845 - 1856
Comparison of survival outcomes of different treatment modalities for patients with primary splenic diffuse large B cell lymphoma Ouyang YonghaoWei YongyangTu Shuju Original Article 15 May 2023 Pages: 1857 - 1865
Retrospective analysis of diagnosis and therapeutic strategies for patients with hepatosplenic T cell lymphoma Youngkyung JeonSang Eun YoonWon Seog Kim Original Article 16 May 2023 Pages: 1867 - 1877
Primary mediastinal/thymic diffuse large B-cell lymphoma: a population-based study on incidence and survival Huijie ZhouQiuluo LiuLiqun Zou Original Article 19 April 2023 Pages: 1879 - 1886
Outcomes of polatuzumab vedotin-containing regimens in real-world setting of relapsed and or refractory diffuse large B-cell lymphoma patients: a matched-control analysis from the Thai Lymphoma Study Group (TLSG) Thanawat RattanathammetheeLalita NorasetthadaTanin Intragumtornchai Original Article 18 May 2023 Pages: 1887 - 1895
Bone marrow biopsy can be omitted in the diagnostic workup of CNS lymphoma of DLBCL origin: a population-based retrospective study in the PET-CT era Jelena JelicicDennis Lund HansenKaren Juul-Jensen Original Article Open access 29 May 2023 Pages: 1897 - 1905
Allogeneic hematopoietic stem cell transplantation remains a feasible approach for elderly with acute myeloid leukemia: a 10-year experience Katarzyna DudaAgata Wieczorkiewicz-KabutGrzegorz Helbig Original Article Open access 19 April 2023 Pages: 1907 - 1914
Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation Massimo MartinoMercedes GoriAnnalisa Pitino Original Article Open access 20 April 2023 Pages: 1915 - 1925
Depression and anxiety among hemophilia patients enrolled in clinical trials: a multi-center cohort study Zhen PengXiaoyu ZhuYin Chen Original Article 22 May 2023 Pages: 1927 - 1937
Deficiency of coagulation factors is associated with the bleeding diathesis of severe yellow fever Mariana Brandão FrancoLeticia Lemos JardimSuely Meireles Rezende Original Article 24 May 2023 Pages: 1939 - 1949
A case of donor cell leukemia driven by a de novo NRAS mutation with complex karyotype Dajeong JeongJa-Yoon GuHyun Kyung Kim Letter to the Editor 31 May 2023 Pages: 1951 - 1952
Interim PET in follicular lymphoma: more patience, please Vít Procházka Letter to the Editor 22 April 2023 Pages: 1953 - 1954
Higher JAK2 V617F mutant allele burden in patients with chronic myeloproliferative neoplasms is associated with a higher prevalence of chronic kidney disease and unfavorable dynamics of kidney function over time Marko LucijanicPetra VeicRajko Kusec Letter to the Editor 03 June 2023 Pages: 1955 - 1956
Hematopoietic status of the whole-body bone marrow in hypoplastic acute promyelocytic leukemia as evaluated by 18F-FLT PET/MRI Hiroaki AraieToshiki TasakiTakahiro Yamauchi Letter to the Editor 08 May 2023 Pages: 1957 - 1959
The effects of anti-CD38 monoclonal antibody and anti-HI antibody on pretransfusion testing in a patient with multiple myeloma Zhe ZhuKairui HongYefang Ke Letter to the Editor 05 May 2023 Pages: 1961 - 1962
Specific symptom burden in patients with chronic myeloproliferative neoplasms and chronic kidney disease Hrvoje HolikMarko LucijanicIvan Krecak Letter to the Editor 31 May 2023 Pages: 1963 - 1965
Correction to: Treatment of hydroxyurea-resistant/intolerant polycythemia vera: a discussion of best practices Andrew T. Kuykendall Correction Open access 24 April 2023 Pages: 1967 - 1967
Correction to: Real‑world imatinib mesylate treatment in patients with chronic myeloid leukemia: The importance of molecular monitoring and the early molecular response Amanda Pifano Soares FerreiraFernanda Salles SeguroIsrael Bendit Correction Open access 09 May 2023 Pages: 1969 - 1969
Correction to: Hemophagocytic lymphohistiocytosis in HIV-associated lymphoproliferative disorders Pascal MigaudMarkus MüllerHartmut Stocker Correction 16 February 2023 Pages: 1971 - 1971